Qualigen Therapeutics receives Nasdaq extension to continue listing through November 19, 2024

AIxCrypto Holdings, Inc.

Received Nasdaq Hearings Panel notice on Sept 11, 2024 granting extension for continued listing.
Must evidence compliance with all applicable Nasdaq criteria by November 19, 2024.
Company is diligently working to fulfill requirements for continued listing on Nasdaq.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.